An Update on the Treatment of Papillary Renal Cell Carcinoma. [PDF]
Cancers (Basel), 2023 Simple Summary Papillary renal cell carcinoma is the second most common type of kidney cancer, after clear cell kidney cancer. Given that it is relatively rare, studying this disease has been quite a challenge.
Chawla NS +5 more
europepmc +4 more sources
Frontiers in Immunology, 2021 PTP4A3 plays an important role in the tumorigenesis and metastasis of multiple tumors, but its prognostic role in renal cancer is not well understood.
Qian Song +7 more
doaj +2 more sources
Biomedicines, 2021 Renal cell carcinoma (RCC) represents a heterogeneous disease, encompassing an increasing number of tumor subtypes. Post-2016, the World Health Organization (WHO) classification recognized that the spectrum of papillary renal cell carcinoma is evolving ...
João Lobo +5 more
doaj +2 more sources
A five-gene signature predicts overall survival of patients with papillary renal cell carcinoma.
PLoS ONE, 2019 BACKGROUND:The present study aims to investigate the gene expression changes in papillary renal cell carcinoma(pRCC) and screen several genes and associated pathways of papillary renal cell carcinoma progression.
Ze Gao +6 more
doaj +2 more sources
Localized abdominal wall metastasis of papillary renal cell carcinoma: a case report [PDF]
Frontiers in SurgeryIntroductionPapillary renal cell carcinoma accounts for one tenth of all renal cell carcinomas. Compared to other renal cell carcinoma subtypes, it is more often localized at the time of diagnosis and rarely metastasizes to the skin.
Chadi Nahal +2 more
doaj +2 more sources
Clear Cell Papillary Renal Cell Carcinoma Incidentally Discovered in a Patient With Normal Renal Function: A Case Report [PDF]
IJU Case ReportsIntroduction Clear cell papillary renal cell carcinoma is a distinct histopathological entity first characterized in patients with end‐stage renal disease.
Toru Inoue +7 more
doaj +2 more sources
Long-term response to nivolumab and acute renal failure in a patient with metastatic papillary renal-cell carcinoma and a PD-L1 tumor expression increased with sunitinib therapy: A case report. [PDF]
Frontiers in Oncology, 2016 Introduction: Papillary renal-cell carcinoma, which represents around 20% of renal cell carcinomas, is a heterogeneous disease that includes different tumor types with several clinical and molecular phenotypes.
Juan Ruiz-Bañobre +5 more
doaj +2 more sources
A synchronous lesion: Papillary renal cell carcinoma mistaken as an adrenal gland mass [PDF]
Radiology Case ReportsIn this case report, we describe a diagnosis of papillary renal cell carcinoma in a 76-year-old male patient who was incidentally found to have a left adrenal mass during routine aneurysm surveillance. Computed tomography demonstrated a left adrenal mass
Cameron Fateri, MD +4 more
doaj +2 more sources
Diagnostic Pathology, 2020 Background The presence of histologically different neoplasms in the same organ is rare in pathologic practice. We report the first case of synchronous clear cell renal cell carcinoma (clear cell RCC) and papillary renal neoplasm with reverse polarity ...
Hyun Jung Lee +8 more
doaj +2 more sources
A case of papillary renal cell carcinoma with para‐aortic lymph node metastasis that was completely resectable after treatment with combination therapy comprising lenvatinib and pembrolizumab and robot‐assisted radical nephrectomy [PDF]
IJU Case ReportsIntroduction Combination therapy comprising immune checkpoint inhibitors and molecular targeted therapies can be effective for metastatic non‐clear cell renal cell carcinoma.
Takayuki Hosoi +6 more
doaj +2 more sources